Merging Nanotechnology and Microfluidics to Develop Targeted Therapies

10 September 2018 11:35 - 12:10

  • Biological Properties of nanoparticles in physiological environments. 
  • Role of microfluidics (lab-on-a-chip and organ-on-a-chip technologies) in paving the way for nanoparticles to the clinic. 

Hagar Labouta, Assistant Professor , University of Manitoba